NKG2D-ligand: Enhancing Carcinoma Infiltration by NKG2D-ligand targeted CAR-T Cells by Co-expression of the Chemokine Receptor CX3CR1 19MA013

FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE

Contact

Haskell Adler PhD MBA CLP
Senior Licensing Manager
Registered Patent Agent
Haskell.Adler@Moffitt.org
(813) 745-6596

19MA013N